Artikel
Transcutaneous aortic valve implantation: short term and mid-term single center results
Suche in Medline nach
Autoren
-
Dorothee H.L. Bail
- Klinikum Bogenhausen, Herzchirurgie, München
-
Michael Lieber
- Klinikum Bogenhausen, Herzchirurgie, München
-
Simone Schleger
- Klinikum Bogenhausen, Herzchirurgie, München
-
Marcus Kasel
- Klinikum Bogenhausen, Kardiologie, München
-
Ellen Hoffmann
- Klinikum Bogenhausen, Kardiologie, München
-
Bernd Kemkes
- Klinikum Bogenhausen, Herzchirurgie, München
-
Jochen Menne
- Klinikum Bogenhausen, Herzchirurgie, München
-
Stefan Sack
- Klinikum Schwabing, Kardiologie, München
-
Walter Eichinger
- Klinikum Bogenhausen, Herzchirurgie, München
| Veröffentlicht: | 20. Mai 2011 |
|---|
Gliederung
Text
Objective: We discribe the mid-term and short term results of transfemoral (TF) and transapical (TA) valve implantation in patients with severe aortic stenosis in our single center.
Methods: A total of 125 high-risk patients underwent transcatheter transfemoral (n = 89; Medtronic CoreValve and Edwards Sapien) or transapical (n = 34; Edwards Sapien) valve implantation from June 2007 to July 2010.
Results: Mean age was in TF 80.2 ± 6.5. and in TA 82.7 ± 6.2 yrs. NYHA class III was 48% in the TF group and 54% in TA. EuroSCORE and STS Score were 18.9/8.7 in the TF and 19/8.3 in the TA group. Perioperativ mortality was 2.5% in TF vs. 0% in TA, thirty-day mortality was 2.5% (TF) vs 4.2% (TA). Vascular complications with the need of surgery occured in 6.7% in TF vs. 0% in TA. Conversion to open surgery was necessary in 3.4% in TF and in no case in TA. Stroke rate was 1.1 % in TF vs. 0% in TA. Sucessrate was 95% in TF and 96% in TA.
Conclusion: Comparing our single center results of the TF vs. the TA approach we conclude that both approaches provide satisfactory results and are comparable with international results. In case of vascular complications and conversion rates the TA approach seems to superior.
